← NewsAll
Eggs could help people quitting weight-loss jabs
Summary
A University of Surrey nutrition expert told The Conversation that eating eggs, a high-protein affordable food, may help ease the common problem of weight regain after stopping GLP-1 weight-loss injections by increasing fullness and stimulating the body's GLP-1 response.
Content
Adam Collins, Associate Professor of Nutrition at the University of Surrey, has written in The Conversation about how eating eggs may help people who stop using GLP-1 weight-loss injections. He says eggs are protein-rich, affordable and can ease the main withdrawal issue — weight regain. Collins notes that long-term studies of GLP-1 drugs show many people regain a substantial portion of lost weight after stopping. He described eggs as acting like a natural GLP-1 agonist because egg protein can trigger the body's GLP-1 release and suppress the hunger hormone ghrelin.
Key points:
- GLP-1 drugs such as Ozempic, Wegovy and Mounjaro suppress appetite, but long-term studies report substantial weight regain after stopping.
- Dr Collins says egg protein can trigger the body's GLP-1 release and suppress ghrelin, which may increase feelings of fullness and reduce later food intake.
- Eggs provide high-quality protein with all essential amino acids, vitamin D and a range of micronutrients, and are described as affordable and sustainable.
- Research cited links protein intakes of around 1 g per kilogram of body weight or higher to greater muscle preservation; eggs can offer a portion-controlled way to help meet protein targets.
- The article notes pairing eggs with fibre-rich foods, such as wholegrain toast, may further boost GLP-1 release, and cites Harvard Health saying one egg a day is safe for most people.
Summary:
Dr Collins presents eggs as a potential, food-based means to reduce appetite and address nutrient shortfalls for people using or stepping away from GLP-1 drugs. The article emphasises that eggs are not a replacement for medications but may help with fullness and protein intake. Undetermined at this time.
